Bank of New York Mellon’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bank of New York Mellon’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-55,737	Closed	-$553K	–	4536
2023 Q1	$553K	Sell	55,737 -204	-0.4%	-$2.02K	﹤0.01%	3444
2022 Q4	$558K	Buy	55,941 +7,594	+16%	+$56.6K	﹤0.01%	3488
2022 Q3	$267K	Buy	48,347 +388	+0.8%	+$2.15K	﹤0.01%	3890
2022 Q2	$175K	Sell	47,959 -351	-0.7%	-$1.66K	﹤0.01%	4105
2022 Q1	$293K	Buy	+48,310	New	+$294K	﹤0.01%	4029
2019 Q3	–	Sell	-11,663	Closed	-$38K	–	4270
2019 Q2	$38K	Sell	11,663 -375	-3%	-$1.33K	﹤0.01%	4144
2019 Q1	$45K	Buy	+12,038	New	+$42.1K	﹤0.01%	4104

Bank of New York Mellon's APEN Position: Q2 2023 in Review

Bank of New York Mellon sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 55,737 shares — an estimated $553K sold.

Bank of New York Mellon first reported a position in APEN in Q1 2019 and held it in 7 quarters. The position peaked at $558K in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Bank of New York Mellon reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Bank of New York Mellon sold 55,737 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $553K.
Bank of New York Mellon first reported a position in Apollo Endosurgery, Inc. in Q1 2019 and held it in 7 quarters.
Bank of New York Mellon's Apollo Endosurgery, Inc. position peaked at $558K in Q4 2022.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Bank of New York Mellon's 13F filing for Q2 2023, filed 3 Aug 2023.